IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Roudy who wrote (160)	12/5/1996 2:26:00 AM
From: I. Luttichuys	of 1762

Hello Don, I wanted to add -- that's great news about CNBC. Let's hope they follow through. I would hope they would. This is a great story with science and human interest. Would you believe I had a discussion with a physician tonight who didn't believe what IDEC is doing was possible? He didn't believe that a working immunoconjugate, relatively indistinguishable from self, with the efficacy C2B8 has shown in phase II was possible. This has been a fantasy of the medical establishment for so long and has been subject to so many disappointments that we've all given up. He openly admits that, if what I showed him of Phase II holds true for Phase III and in the clinic, it will be "a whole new world". He is a good physician who cares deeply for his patients and you could see the appreciation he would have for the opportunity to be able to offer such an alternative as C2B8. We had quite a lengthy discussion and suffice it to say, we are meeting to look over the press release for Phase III when it hits the wires. The media really needs to bring this one to light. Have a good evening, BENNETT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next